Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Lancet Infect Dis. 2022 Aug 8;23(1):e2–e21. doi: 10.1016/S1473-3099(22)00291-2

Figure 3: RSV vaccine and mAb candidates by target population.

Figure 3:

Vaccine candidates and mAbs are categorized into three different target populations: (1) pediatric, (2) maternal, and (3) older adults and clinical phase of development: Phase I, II, or III. Different immunization approaches are indicated by the legend at the bottom. The route of administration is indicated in the small purple circles at the right: (1) intramuscular (IM), (2) intranasal (IN), (3) intradermal.